SLDB Solid Biosciences Inc.
NEUTRAL
Impact: 2/10
8-K
8-K context-dependent: Items 5.02
Latest settled — T+20d
SLDB ▼ -8.46% at T+20d
NEUTRAL call ✗ call lost -8.46% · α vs SPY -16.19% · entry $8.39 → $7.68
Currently $7.14 · -14.90% from $8.39 entry
T+1d
-1.91%
call -1.91% · α -3.12%
$8.23
settled 2mo ago
T+5d
+1.19%
call +1.19% · α -2.10%
$8.49
settled 8w ago
T+20d
-8.46%
call -8.46% · α -16.19%
$7.68
settled 5w ago
T+60d
—
call — · α —
—
in 24d
Price Chart
Loading chart...
Executive Summary
Solid Biosciences Inc. announced a board seat reclassification for director Ilan Ganot, who resigned from Class III and was immediately reappointed to Class I to balance board composition. The move is procedural and does not reflect a change in leadership or strategy.
Actionable Insight
This is a routine corporate governance adjustment with no operational or strategic implications. Traders should not expect stock movement based on this filing.
Key Facts
- Ilan Ganot resigned from Class III of the Board and was reappointed to Class I effective April 10, 2026
- The change was made to achieve equal balance among the three board classes
- No changes to Ganot's compensation or role responsibilities were made
- Stockholders will be asked to ratify the appointment on an advisory basis at the 2026 Annual Meeting
Financial Impact
No financial impact
compensationboard structure
Risk Factors
- Advisory ratification at the 2026 Annual Meeting could face shareholder opposition, though unlikely given the procedural nature
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-151259 |
| Document: 0001193125-26-151259-index-headers.html | 0001193125-26-151259 |
| Document: 0001193125-26-151259-index.html | 0001193125-26-151259 |
| Document: 0001193125-26-151259.txt | 0001193125-26-151259 |
10 reports for SLDB
100%
Hit rate
best @ T+20▲ +20.77%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 12, 2026
4w ago
|
Press Release
| $7.38 $6.08 | ▲ +17.62% | ▲ +16.46% | $7.14 (+3.25%) |
|
May 7, 2026
5w ago
|
Press Release
| $7.07 $7.38 | ▲ +4.38% | ▲ +2.88% | $7.14 (+0.99%) |
|
Apr 23, 2026
7w ago
|
DEFA14A
| $7.92 $7.26 | ▼ −8.33% | ▼ −9.24% | $7.14 (−9.85%) |
|
Apr 10, 2026
9w ago
|
8-K
| $8.39 $8.49 | ▲ +1.19% | ▼ −2.10% | $7.14 (−14.90%) |
|
Apr 1, 2026
10w ago
|
EFFECT
| $7.38 $8.10 | ▼ −9.76% | ▼ −5.99% | $7.14 (+3.25%) |
|
Mar 19, 2026
12w ago
|
Press Release
| $7.03 $7.11 | ▲ +1.14% | ▲ +3.29% | $7.14 (+1.56%) |
|
Mar 12, 2026
13w ago
|
8-K
| $7.71 $7.12 | ▼ −7.65% | ▼ −6.67% | $7.14 (−7.39%) |
|
Mar 11, 2026
13w ago
|
Press Release
| $7.72 $7.12 | ▼ −7.71% | ▼ −5.52% | $7.14 (−7.45%) |
|
Mar 6, 2026
14w ago
|
Press Release
| $6.75 $7.31 | ▲ +8.30% | ▲ +9.82% | $7.14 (+5.78%) |
|
Mar 2, 2026
14w ago
|
Press Release
| $5.96 $8.18 | ▲ +37.25% | ▲ +37.73% | $7.14 (+19.80%) |
Showing 10 of 10
US Market Status
Market Closed — Opens Mon (47h 24m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access